Detalhe da pesquisa
1.
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029.
Cancer
; 129(2): 264-271, 2023 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36420773
2.
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients.
Cancer Cell Int
; 23(1): 165, 2023 Aug 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37568162
3.
Racial disparities in cascade testing for cancer predisposition genes.
Prev Med
; 172: 107539, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37156429
4.
Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor.
J Urol
; 208(3): 641-649, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35674780
5.
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Cancer
; 127(20): 3751-3760, 2021 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34260067
6.
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
Invest New Drugs
; 39(6): 1656-1663, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34031784
7.
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
Cancer
; 126(19): 4353-4361, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32697352
8.
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
J Natl Compr Canc Netw
; 17(5): 459-468, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31085753
9.
Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
Breast Cancer Res
; 20(1): 35, 2018 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29720215
10.
Impact of primary breast cancer therapy on energetic capacity and body composition.
Breast Cancer Res Treat
; 172(2): 445-452, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30136009
11.
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.
J Natl Compr Canc Netw
; 16(3): 257-265, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29523664
12.
Lower expression of tumor microRNA-26a is associated with higher recurrence in patients with hepatocellular carcinoma undergoing surgical treatment.
J Surg Oncol
; 118(3): 431-439, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30076741
13.
Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
Oncologist
; 21(6): 664-5, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27256874
14.
TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.
Breast Cancer Res Treat
; 152(3): 519-31, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26160249
15.
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.
Breast Cancer Res Treat
; 148(1): 99-106, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25257727
16.
Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resections.
J Neurooncol
; 118(1): 117-22, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24532242
17.
Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer.
Sci Rep
; 14(1): 1029, 2024 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38200207
18.
Early Discharge of Adolescent and Young Adult Patients During Induction Chemotherapy for Newly Diagnosed Acute Lymphoblastic Leukemia: Is It Safe?
J Adolesc Young Adult Oncol
; 12(2): 271-274, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35852828
19.
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
JCO Precis Oncol
; 7: e2200465, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36787505
20.
Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors.
J Clin Oncol
; 41(23): 3939-3944, 2023 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36758196